Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
All content for Fenben® Voices is the property of Fenbendazole Help and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
S1EP11 Fenbendazole and Cancer: Unveiling the Truth Behind the Controversy
Fenben® Voices
4 minutes
1 year ago
S1EP11 Fenbendazole and Cancer: Unveiling the Truth Behind the Controversy
Got Questions? Send us a message!Dive into a nuanced discussion on "Fenben Voices" about Fenbendazole's journey from a veterinary dewormer to its debated role in cancer therapy. This episode untangles the web of scientific studies, personal testimonies, and controversies to offer a comprehensive look at:Fenbendazole’s deworming roots and microtubule connection.The cautious optimism from preliminary research and the push for clinical trials.The skepticism from lack of rigorous studies and regu...
Fenben® Voices
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
